Zhou T, Damsky W, Weizman O, McGeary M, Hartmann K, Rosen C, et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. Nature. 2020;583:609-614 pubmed publisher

Upadhyay R, Boiarsky J, Pantsulaia G, Svensson Arvelund J, Lin M, Wroblewska A, et al. A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy. Cancer Discov. 2021;11:599-613 pubmed publisher

Lotti R, Shu E, Petrachi T, Marconi A, Palazzo E, Quadri M, et al. Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus. Front Immunol. 2018;9:370 pubmed publisher

Lakins M, Ghorani E, Munir H, Martins C, Shields J. Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells. Nat Commun. 2018;9:948 pubmed publisher

BieÅ„ K, Å»migrodzka M, OrÅ‚owski P, Fruba A, SzymaÅ„ski Å, Stankiewicz W, et al. Involvement of Fas/FasL pathway in the murine model of atopic dermatitis. Inflamm Res. 2017;66:679-690 pubmed publisher

D Aloia M, Caratelli S, Palumbo C, Battella S, Arriga R, Lauro D, et al. T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G-opsonized target cells. Cytotherapy. 2016;18:278-90 pubmed publisher

Linkermann A, Himmerkus N, Rölver L, Keyser K, Steen P, Bräsen J, et al. Renal tubular Fas ligand mediates fratricide in cisplatin-induced acute kidney failure. Kidney Int. 2011;79:169-78 pubmed publisher